SCHEMBL5263213

SCHEMBL5263213

COc1cc2c(Cl)nc(-c3ccc(Cl)cc3)nc2c(OC)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHPS P49366 7/20 0.49
▸ PDE5A O76074 3/20 0.46
▸ EGFR P00533 3/20 0.42
▸ PDGFRB P09619 1/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ PIK3CA P42336 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ PTK2B Q14289 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TUBB4A P04350 1/20 0.39
▸ TUBB P07437 1/20 0.39
▸ TUBA3C P0DPH7 1/20 0.39
▸ TUBA1B P68363 1/20 0.39
▸ TUBA4A P68366 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5259174 0.86 PDE5A (0.44) DHPSPDE5AEGFRPDGFRBJAK2
SCHEMBL15966833 0.80 ALDH1A1 (0.49) PDGFRBMAPTMEN1KMT2ATUBB4A
SCHEMBL5258591 0.79 WHR1 (0.55) DHPSEGFRPDGFRBTHRBLMNA
SCHEMBL7261425 0.79 PDE1B (0.60) DHPSPDE5AEGFRPDGFRBJAK2
SCHEMBL5259886 0.79 HPGD (0.40) PDE5AEGFRLMNAMAPTTP53
SCHEMBL7268608 0.78 PDE5A (0.51) DHPSPDE5ATHRBMEN1KMT2A
SCHEMBL7266347 0.78 MEN1 (0.53) PDE5ATHRBLMNAMAPTMEN1
SCHEMBL7261986 0.77 NPSR1 (0.47) PDE5AEGFRLMNAMAPTMEN1
SCHEMBL7261507 0.77 ALDH1A1 (0.52) PIK3CAPIK3CBPIK3CGMAPT
Hydrochloric Acid SCHEMBL7262070 0.77 PDE5A (0.50) PDE5ATHRBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040101-B1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS SANOFI AVENTIS DEUTSCHLAND (DE) 2007-04-25 — — EP disclosed
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 — — US disclosed
EP-1040101-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS Aventis Pharma Deutschland GmbH (DE) 2000-10-04 — — EP disclosed
WO-1999032460-A1 SUBSTITUTED 2-ARYL-4-AMINO-CHINAZOLINES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-01 — — WO disclosed
Send feedback